We report an HPLC assay for melatonin that incorporates automated injection, methanol/water mobile phase, and fluorescence detection. Plasma samples were extracted by solid and liquid phases. Recovery was >70% for 1-10 mL of plasma extracted, ∼40 pg-250 ng of melatonin. Samples were dried and reconstituted in 100 mL/L methanol. Injections were 25 μL or 150 μL, depending on sample concentration, and the melatonin peak was eluted in 380 mL/L methanol. The detection limit of the assay was 6 pg on the column, allowing a practical sensitivity in plasma of 11 pmol/L for 8-mL samples and 34 pmol/L for 2-mL samples. More than 100 plasma samples from volunteers and patients were assayed and the results compared with an established RIA. The mean daytime concentration of melatonin was 20.7 pmol/L (SEM = 1.2) and 18.5 pmol/L (SEM = 1.6) for HPLC and RIA, respectively, and the mean nighttime concentration was 82.4 pmol/L (SEM = 6.5) and 82.2 (SEM = 7.3), respectively.
CITATION STYLE
Peniston-Bird, J. F., Di, W. L., Street, C. A., Kadva, A., Stalteri, M. A., & Silman, R. E. (1993). HPLC assay of melatonin in plasma with fluorescence detection. Clinical Chemistry, 39(11), 2242–2247. https://doi.org/10.1093/clinchem/39.11.2242
Mendeley helps you to discover research relevant for your work.